PE20190476A1 - Compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica - Google Patents
Compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion viricaInfo
- Publication number
- PE20190476A1 PE20190476A1 PE2019000346A PE2019000346A PE20190476A1 PE 20190476 A1 PE20190476 A1 PE 20190476A1 PE 2019000346 A PE2019000346 A PE 2019000346A PE 2019000346 A PE2019000346 A PE 2019000346A PE 20190476 A1 PE20190476 A1 PE 20190476A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- benzyl
- treatment
- substituted
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se refiere a nuevos derivados sulfonimidoilpurinonas, compuestos de formula (I): en la que R1 es alquilo C1-C6, entre otros; R2 es bencilo, estando dicho bencilo no sustituido o sustituidos seleccionados independientemente entre halogeno y alquilo C1-C6, entre otros; y R3 es -NR4R5, entre otros, R4 es alquilo C1-C6, R5 es (alquil C1-C6)2NCOO-alquiloC1-C6. Son compuestos preferidos de entre: 6-amino-9-bencil-N-metil-8-oxo-N-propil-2-(propilsulfonimidoil)purin-7-carboxamida; 6-amino-9-bencil-N-(2-metoxietil)-N-metil-8-oxo-2-(propilsulfonimidoil)purin-7-carboxamida. Dichos compuestos presentan actividad agonista de receptor de tipo Toll in vivo que detectan patogenos invasores y el posterior inicio de respuestas inmunologicas innatas; tambien se refiere a una composicion farmaceutica y es util en el tratamiento o la prevencion de enfermedades infecciosas como VHB o VHC.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2016097140 | 2016-08-29 | ||
| CN2017092653 | 2017-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20190476A1 true PE20190476A1 (es) | 2019-04-04 |
Family
ID=59738346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2019000346A PE20190476A1 (es) | 2016-08-29 | 2017-08-28 | Compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US10233184B2 (es) |
| EP (2) | EP3504210B1 (es) |
| JP (2) | JP7013467B2 (es) |
| KR (2) | KR102459155B1 (es) |
| CN (1) | CN109641904B (es) |
| AU (3) | AU2017320742B2 (es) |
| CA (1) | CA3034148A1 (es) |
| CL (1) | CL2019000512A1 (es) |
| CO (1) | CO2019000932A2 (es) |
| CR (1) | CR20190087A (es) |
| DK (1) | DK3504210T3 (es) |
| ES (1) | ES2867849T3 (es) |
| HR (1) | HRP20210621T1 (es) |
| HU (1) | HUE053944T2 (es) |
| IL (3) | IL284255B (es) |
| MA (1) | MA46038B1 (es) |
| MX (2) | MX2019002129A (es) |
| MY (1) | MY197408A (es) |
| PE (1) | PE20190476A1 (es) |
| PH (1) | PH12019500432B1 (es) |
| PL (1) | PL3504210T3 (es) |
| PT (1) | PT3504210T (es) |
| RS (1) | RS61752B1 (es) |
| RU (1) | RU2751349C2 (es) |
| SG (2) | SG10202010520SA (es) |
| SI (1) | SI3504210T1 (es) |
| TW (1) | TWI671300B (es) |
| UA (1) | UA124270C2 (es) |
| WO (1) | WO2018041763A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ775222A (en) * | 2015-05-08 | 2024-09-27 | Hoffmann La Roche | Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection |
| MX2019002129A (es) * | 2016-08-29 | 2019-06-20 | Hoffmann La Roche | Nuevos compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica. |
| CA3034185A1 (en) * | 2016-09-13 | 2018-03-22 | F. Hoffmann-La Roche Ag | Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor |
| JP7328977B2 (ja) | 2018-02-12 | 2023-08-17 | エフ． ホフマン－ラ ロシュ アーゲー | ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体 |
| BR112020016509A2 (pt) * | 2018-02-28 | 2020-12-15 | F. Hoffmann-La Roche Ag | Composto, composto para uso no tratamento ou profilaxia do câncer de fígado, composição farmacêutica ou medicamento, uso e método para o tratamento ou profilaxia do câncer de fígado |
| CA3111784A1 (en) | 2018-09-12 | 2020-03-19 | Silverback Therapeutics, Inc. | Methods and compositions for the treatment of disease with immune stimulatory conjugates |
| WO2020162705A1 (ko) | 2019-02-08 | 2020-08-13 | 성균관대학교산학협력단 | 톨-유사 수용체 7 또는 8 작용자와 콜레스테롤의 결합체 및 그 용도 |
| AU2020358726A1 (en) | 2019-10-01 | 2022-04-07 | Silverback Therapeutics, Inc. | Combination therapy with immune stimulatory conjugates |
| JP2023514727A (ja) | 2020-02-21 | 2023-04-07 | シルバーバック セラピューティックス インコーポレイテッド | ネクチン－４抗体コンジュゲートおよびその使用 |
| CA3170551A1 (en) | 2020-03-02 | 2021-09-10 | Yong Taik Lim | Live-pathogen-mimetic nanoparticles based on pathogen cell wall skeleton, and production method thereof |
| IL299508A (en) | 2020-07-01 | 2023-02-01 | Ars Pharmaceuticals Inc | Anti-asgr1 antibody conjugates and uses thereof |
| EP4194006A4 (en) | 2020-08-04 | 2024-12-04 | Progeneer Inc. | mRNA VACCINE WITH AN ADJUVANT CAPABLE OF KINETIC CONTROL |
| WO2022031057A1 (ko) | 2020-08-04 | 2022-02-10 | 성균관대학교산학협력단 | 활성화 부위가 일시적으로 비활성화된 톨-유사 수용체 7 또는 8 작용자와 기능성 약물의 결합체 및 그 용도 |
| EP4194008A4 (en) | 2020-08-04 | 2025-01-08 | Progeneer Inc | KINETIC ACTION ADJUVANT SET |
| CN114315861A (zh) * | 2020-09-27 | 2022-04-12 | 上海维申医药有限公司 | 大环tlr7激动剂、其制备方法、药物组合物及其用途 |
| GB202306325D0 (en) | 2023-04-28 | 2023-06-14 | Iksuda Therapeutics Ltd | Antibody-drug conjugate compounds, and methods of use and treatment |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0141927B1 (en) * | 1983-08-18 | 1991-10-30 | Beecham Group Plc | Antiviral guanine derivatives |
| AU698419B2 (en) | 1996-07-03 | 1998-10-29 | Dainippon Sumitomo Pharma Co., Ltd. | A novel purine derivative |
| AUPO912997A0 (en) | 1997-09-11 | 1997-10-02 | Commonwealth Scientific And Industrial Research Organisation | Antiviral agents |
| CA2311742C (en) | 1997-11-28 | 2009-06-16 | Sumitomo Pharmaceuticals Co., Ltd. | 6-amino-9-benzyl-8-hydroxypurine derivatives |
| JPH11180981A (ja) * | 1997-12-19 | 1999-07-06 | Sumitomo Pharmaceut Co Ltd | 複素環誘導体 |
| TW572758B (en) | 1997-12-22 | 2004-01-21 | Sumitomo Pharma | Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives |
| JP4189048B2 (ja) * | 1997-12-26 | 2008-12-03 | 大日本住友製薬株式会社 | 複素環化合物 |
| CA2479037C (en) | 2002-03-15 | 2010-11-09 | Jiri Zemlicka | 2-amino-9[(2-hydroxymethyl)cyclopropylidenemethyl]purines as antiviral agents |
| NZ539064A (en) * | 2002-09-27 | 2007-09-28 | Dainippon Sumitomo Pharma Co | Novel adenine compound and use thereof |
| EA200702235A1 (ru) | 2005-05-04 | 2008-04-28 | Пфайзер Лимитед | Производные 2-амидо-6-амино-8-оксопурина в качестве модуляторов toll-подобных рецепторов для лечения рака и вирусных инфекций, таких как гепатит с |
| DE102006053049A1 (de) | 2006-11-10 | 2008-05-15 | Daimler Ag | Staufach mit einer Abdeckeinrichtung |
| PT2170888E (pt) * | 2007-06-29 | 2015-08-21 | Gilead Sciences Inc | Purina derivados e sua utilização como moduladores de recetor de tipo toll 7 |
| CN101239980B (zh) | 2008-02-18 | 2011-06-22 | 靳广毅 | 免疫受体调节剂偶联体前体和偶联体及其应用 |
| AP2011005745A0 (en) * | 2008-12-09 | 2011-06-30 | Gilead Sciences Inc | Modulators of toll-like receptors. |
| CA2777824C (en) * | 2009-10-22 | 2016-11-29 | Gilead Sciences, Inc. | Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections |
| WO2011079016A1 (en) | 2009-12-22 | 2011-06-30 | Gilead Sciences, Inc. | Methods of treating hbv and hcv infection |
| US8501724B1 (en) * | 2012-01-31 | 2013-08-06 | Pharmacyclics, Inc. | Purinone compounds as kinase inhibitors |
| PT3190113T (pt) | 2014-08-15 | 2021-06-17 | Chai Tai Tianqing Pharmaceutical Group Co Ltd | Compostos pirrolopirimidina utilizados como agonistas de tlr7 |
| NZ775222A (en) * | 2015-05-08 | 2024-09-27 | Hoffmann La Roche | Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection |
| MX2019002129A (es) * | 2016-08-29 | 2019-06-20 | Hoffmann La Roche | Nuevos compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica. |
-
2017
- 2017-08-28 MX MX2019002129A patent/MX2019002129A/es unknown
- 2017-08-28 CN CN201780052692.6A patent/CN109641904B/zh active Active
- 2017-08-28 RS RS20210489A patent/RS61752B1/sr unknown
- 2017-08-28 KR KR1020197008982A patent/KR102459155B1/ko active Active
- 2017-08-28 PL PL17758527T patent/PL3504210T3/pl unknown
- 2017-08-28 CR CR20190087A patent/CR20190087A/es unknown
- 2017-08-28 CA CA3034148A patent/CA3034148A1/en active Pending
- 2017-08-28 EP EP17758527.0A patent/EP3504210B1/en active Active
- 2017-08-28 SG SG10202010520SA patent/SG10202010520SA/en unknown
- 2017-08-28 RU RU2019107957A patent/RU2751349C2/ru active
- 2017-08-28 AU AU2017320742A patent/AU2017320742B2/en active Active
- 2017-08-28 DK DK17758527.0T patent/DK3504210T3/da active
- 2017-08-28 KR KR1020227036198A patent/KR20220147702A/ko not_active Ceased
- 2017-08-28 IL IL284255A patent/IL284255B/en unknown
- 2017-08-28 IL IL293475A patent/IL293475B2/en unknown
- 2017-08-28 TW TW106129087A patent/TWI671300B/zh active
- 2017-08-28 PH PH1/2019/500432A patent/PH12019500432B1/en unknown
- 2017-08-28 SI SI201730728T patent/SI3504210T1/sl unknown
- 2017-08-28 UA UAA201903059A patent/UA124270C2/uk unknown
- 2017-08-28 PE PE2019000346A patent/PE20190476A1/es unknown
- 2017-08-28 HU HUE17758527A patent/HUE053944T2/hu unknown
- 2017-08-28 WO PCT/EP2017/071514 patent/WO2018041763A1/en active Application Filing
- 2017-08-28 JP JP2019532184A patent/JP7013467B2/ja active Active
- 2017-08-28 ES ES17758527T patent/ES2867849T3/es active Active
- 2017-08-28 EP EP20207475.3A patent/EP3865482A1/en not_active Withdrawn
- 2017-08-28 MA MA46038A patent/MA46038B1/fr unknown
- 2017-08-28 PT PT177585270T patent/PT3504210T/pt unknown
- 2017-08-28 MY MYPI2019001082A patent/MY197408A/en unknown
- 2017-08-28 SG SG11201901633WA patent/SG11201901633WA/en unknown
- 2017-08-29 US US15/689,136 patent/US10233184B2/en active Active
-
2019
- 2019-01-29 US US16/260,744 patent/US10752630B2/en active Active
- 2019-01-30 CO CONC2019/0000932A patent/CO2019000932A2/es unknown
- 2019-02-07 IL IL264710A patent/IL264710B/en unknown
- 2019-02-21 MX MX2021006902A patent/MX2021006902A/es unknown
- 2019-02-26 CL CL2019000512A patent/CL2019000512A1/es unknown
-
2020
- 2020-08-24 US US17/001,572 patent/US20200385387A1/en not_active Abandoned
-
2021
- 2021-04-19 HR HRP20210621TT patent/HRP20210621T1/hr unknown
- 2021-06-24 AU AU2021204303A patent/AU2021204303B2/en active Active
-
2022
- 2022-01-17 JP JP2022004832A patent/JP7214900B2/ja active Active
- 2022-06-30 AU AU2022204697A patent/AU2022204697A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20190476A1 (es) | Compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica | |
| CL2018003492A1 (es) | Hepatitis b agentes antivirales. | |
| CL2021001288A1 (es) | Heterociclos funcionalizados como agentes antivirales | |
| CY1124404T1 (el) | Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5 και μεθοδοι χρησης αυτων | |
| CL2018002528A1 (es) | Agentes anti virales de la hepatitis b. | |
| PE20160686A1 (es) | Nuevas dihidroquinolizinonas para el tratamiento y profilaxis de la infeccion por virus de la hepatitis b | |
| PE20181298A1 (es) | Inhibidores de bromodominio bivalentes y usos de los mismos | |
| EA202092896A1 (ru) | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона | |
| PE20150776A1 (es) | 6-aminoacido-heteroarildihidropirimidinas para el tratamiento y profilaxis de la infeccion del virus de la hepatitis b | |
| UY37997A (es) | Agentes antivirales contra la hepatitis b | |
| CL2017001426A1 (es) | Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales. | |
| CL2016002179A1 (es) | Nuevas heteroarildihidropirimidinas 6-fusionadas para el tratamiento y la profilaxis de la infección por virus de la hepatitis b. | |
| PE20220567A1 (es) | Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| PE20161066A1 (es) | Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos | |
| CU20180011A7 (es) | Composiciones farmacéuticas que comprenden compuestos derivados de diaminopirido (3,2-d) como moduladores de receptor de tipo toll | |
| CL2013002299A1 (es) | Compuestos derivados de heterociclos, inhibidores de la replicacion del virus de la hepatitis c; composicion farmaceutica que los comprende; util en el tratamiento de una infeccion por vhc. (divisional solicitud 689-2011). | |
| MX376106B (es) | Nuevas piridazonas y triazinonas para el tratamiento y la profilaxis de infección por virus de hepatitis b. | |
| MX374296B (es) | Compuestos de pirazina novedosos para el tratamiento de enfermedades infecciosas | |
| EA201592126A1 (ru) | 6-мостиковые гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b | |
| PE20191461A1 (es) | Compuestos amida para el tratamiento del vih | |
| MX2010009995A (es) | Heterociclos puenteados como inhibidores de la integrasa del virus de inmunodeficiencia humana. | |
| UY38383A (es) | Heterociclos funcionalizados como agentes antivirales | |
| EA201791058A1 (ru) | Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4) | |
| PE20180024A1 (es) | Triazolopirazinonas como inhibidores de pde1 | |
| PE20161379A1 (es) | Nuevos compuestos macrociclicos |